Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Physiologic Hyperglucogonemia on Adipocyte Metabolism
NCT04300049Phase 1Completed
- Sponsor
- UT Health San Antonio
- Start
- Feb 2018
- Primary completion
- Nov 2023
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of glucagon, sponsored by UT Health San Antonio. Primary endpoint: Rate of Glycerol Turnover at 12 hours. Started Feb 2018; status: completed.
02
Drugs
glucagon
Beyond the preview
Go deeper on NCT04300049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04300049.